Delivery Order SPE2DB22D3501-SPE2DB25FWV77
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Oxycodone HCL (Immediate Release) 5 mg tablets in quantities of 100 under a firm fixed-price contract valued at $1,279.58. This non-set-aside award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a small-value pharmaceutical delivery. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract provides for the delivery of 4564015075 - Oxycodone HCl 5 mg/5 ml Cup UD 5 ml to support military treatment programs and facilities. The award has a ceiling value of $4,227.05 and an ultimate completion date of March 20, 2024. AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,605,228 units of Oxycodone HCl 5 mg/5 ml medication. The $1,765.20 contract has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used. This contract is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,700 to Amerisourcebergen Drug Corporation for oxycodone hydrochloride immediate release 5 mg tablets. As the prime contractor, Amerisourcebergen will deliver 100 count bottles of the pharmaceutical product. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 8, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,618 to Amerisourcebergen Drug Corporation for oxycodone hydrochloride 5 mg/5 ml cups. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania in support of the agency's medical supply chain requirements. No subcontractors or set aside designations were identified. As a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 3, 2025, for the supply of OxyContin tablets 20mg, with a ceiling value of $3,304.45. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OXYCODONE HCL 5 MG/5 ML CUP UD 5ML. The contract has a firm fixed price, with a ceiling value of $4,553.44, and an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,108,069 units of oxycodone hydrochloride 5 mg tablets in 100-count bottles. The contract has a firm fixed price of $1,573.14 and a completion date of May 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 20, 2025, for OxyContin tablets (20mg) with a ceiling value of $3,304.45. This is a firm fixed-price delivery order, classified as a child contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract has an ultimate completion...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,211.18 firm fixed-price contract is for the supply of 4565165480 - Oxycodone HCL 5 mg/5 ml cups with a 5 ml dosage. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWV77Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Oxycodone HCL 5 mg/5 mL unit dose cups (5 mL volume) with a ceiling value of $1,883.02. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement through December 2026 that provides comprehensive global pharmaceutical support for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill open competition requirements across a diverse range of pharmaceutical products and medical supplies, including both brand-name and generic medications. This specific delivery order for controlled pharmaceutical inventory reflects the company's ongoing role in supporting military medical supply chain requirements through the DLA's comprehensive pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/13/25 |